Viosera Therapeutics

Viosera Therapeutics is a predict and block drug resistance in cancer and bacteria.

Launch date

Jul 2016

Employees

Market cap

Net debt

-

Enterprise valuation

$2m (Public information from Mar 2019)

Sunnyvale California (HQ), San Francisco United States (HQ)

https://www.viosera.com/

https://twitter.com/vioseratherapy https://www.linkedin.com/company/viosera-therapeutics

Authorizing premium user...